Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Nov;60(5):775–780. doi: 10.1038/bjc.1989.358

Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma.

J Tucker 1, P F Prior 1, C R Green 1, G M Ede 1, J F Stevenson 1, J Gawler 1, G A Jamal 1, M Charlesworth 1, C M Thakkar 1, P Patel 1, et al.
PMCID: PMC2247319  PMID: 2508738

Abstract

The potential long-term toxicity of central nervous system prophylaxis (CNS-P) in adult acute lymphoblastic leukaemia (ALL, n = 17) and non-Hodgkin's lymphoma (NHL, n = 7) was investigated in a multidisciplinary study. At least 4 years had elapsed from CNS-P (mean 11.5 years) for all patients. Neurological history and physical examination were unremarkable; minor signs were commoner in older patients (P less than 0.02). Psychometry yielded normal results, but individual verbal IQ generally exceeded performance IQ, with a trend to more marked differences in younger adults (P = 0.06). EEG was scored and differed significantly from that of controls, with a tendency to more marked (but still minor) abnormalities in younger patients (P = 0.06). Brainstem auditory evoked potentials demonstrated significant but generally minor abnormality in 24% of patients. CT brain scan revealed widening of cerebral hemisphere sulci to greater than 3 mm in 38% of patients; cerebral atrophy was commoner in the older group (P less than 0.02) and those with neurological signs (P less than 0.02). MRI brain scans were normal in all patients tested. Thus, following standard CNS-P for ALL at this hospital, there is a 5% primary CNS relapse rate, and only minimal, mainly subclinical, long-term neuropsychological toxicity.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aur R. J., Simone J., Hustu H. O., Walters T., Borella L., Pratt C., Pinkel D. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood. 1971 Mar;37(3):272–281. [PubMed] [Google Scholar]
  2. Barnett M. J., Greaves M. F., Amess J. A., Gregory W. M., Rohatiner A. Z., Dhaliwal H. S., Slevin M. L., Biruls R., Malpas J. S., Lister T. A. Treatment of acute lymphoblastic leukaemia in adults. Br J Haematol. 1986 Nov;64(3):455–468. doi: 10.1111/j.1365-2141.1986.tb02201.x. [DOI] [PubMed] [Google Scholar]
  3. Binnie C. D., Batchelor B. G., Bowring P. A., Darby C. E., Herbert L., Lloyd D. S., Smith D. M., Smith G. F., Smith M. Computer-assisted interpretation of clinical EEGs. Electroencephalogr Clin Neurophysiol. 1978 May;44(5):575–585. doi: 10.1016/0013-4694(78)90125-6. [DOI] [PubMed] [Google Scholar]
  4. Bleyer W. A., Poplack D. G. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun;12(2):131–148. [PubMed] [Google Scholar]
  5. Brouwers P., Riccardi R., Fedio P., Poplack D. G. Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr. 1985 May;106(5):723–728. doi: 10.1016/s0022-3476(85)80343-7. [DOI] [PubMed] [Google Scholar]
  6. Carli M., Perilongo G., Laverda A. M., Drigo P., Casara G. L., Marin G., Sotti G., Deambrosis G., Zanesco L. Risk factors in long-term sequelae of central nervous system prophylaxis in successfully treated children with acute lymphocytic leukemia. Med Pediatr Oncol. 1985;13(6):334–340. doi: 10.1002/mpo.2950130607. [DOI] [PubMed] [Google Scholar]
  7. Curnes J. T., Laster D. W., Ball M. R., Moody D. M., Witcofski R. L. MRI of radiation injury to the brain. AJR Am J Roentgenol. 1986 Jul;147(1):119–124. doi: 10.2214/ajr.147.1.119. [DOI] [PubMed] [Google Scholar]
  8. Eiser C. Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child. 1978 May;53(5):391–395. doi: 10.1136/adc.53.5.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Komp D. M., Fernandez C. H., Falletta J. M., Ragab A. H., Humphrey G. B., Pullen J., Moon T., Shuster J. CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study. Cancer. 1982 Sep 15;50(6):1031–1036. doi: 10.1002/1097-0142(19820915)50:6<1031::aid-cncr2820500602>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  10. Linker C. A., Levitt L. J., O'Donnell M., Ries C. A., Link M. P., Forman S. J., Farbstein M. J. Improved results of treatment of adult acute lymphoblastic leukemia. Blood. 1987 Apr;69(4):1242–1248. [PubMed] [Google Scholar]
  11. Lister T. A., Cullen M. H., Brearley R. B., Beard M. E., Stansfeld A. G., Whitehouse J. M., Wrigley P. F., Ford J. M., Malpas J. S., Crowther D. Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology. Cancer Chemother Pharmacol. 1978;1(2):107–112. doi: 10.1007/BF00254044. [DOI] [PubMed] [Google Scholar]
  12. Lister T. A., Whitehouse J. M., Beard M. E., Paxton A., Brearley R. L., Brown L., Wrigley P. F., Crowther D. Early central nervous system involvement in adults with acute non-myelogenous leukaemia. Br J Cancer. 1977 Apr;35(4):479–483. doi: 10.1038/bjc.1977.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Margerison J. H., Binnie C. D., McCaul I. R. Electroencephalographic signs employed in the location of ruptured intracranial arterial aneurysms. Electroencephalogr Clin Neurophysiol. 1970 Mar;28(3):296–306. doi: 10.1016/0013-4694(70)90166-5. [DOI] [PubMed] [Google Scholar]
  14. Meadows A. T., Gordon J., Massari D. J., Littman P., Fergusson J., Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet. 1981 Nov 7;2(8254):1015–1018. doi: 10.1016/s0140-6736(81)91216-2. [DOI] [PubMed] [Google Scholar]
  15. Moss H. A., Nannis E. D., Poplack D. G. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med. 1981 Jul;71(1):47–52. doi: 10.1016/0002-9343(81)90257-6. [DOI] [PubMed] [Google Scholar]
  16. Nesbit M. E., Jr, Sather H. N., Robison L. L., Ortega J., Littman P. S., D'Angio G. J., Hammond G. D. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group. Lancet. 1981 Feb 28;1(8218):461–466. doi: 10.1016/s0140-6736(81)91849-3. [DOI] [PubMed] [Google Scholar]
  17. Omura G. A., Moffitt S., Vogler W. R., Salter M. M. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. Blood. 1980 Feb;55(2):199–204. [PubMed] [Google Scholar]
  18. Rowland J. H., Glidewell O. J., Sibley R. F., Holland J. C., Tull R., Berman A., Brecher M. L., Harris M., Glicksman A. S., Forman E. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol. 1984 Dec;2(12):1327–1335. doi: 10.1200/JCO.1984.2.12.1327. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES